Cargando…

S6.4c Primary cutaneous implantation coccidioidomycosis

S6.4 ONE HEALTH APPROACH FOR ENDEMIC MYCOES IN THE AMERICAS, SEPTEMBER 22, 2022, 4:45 PM - 6:15 PM:   OBJECTIVE: To present a series of cases of primary cutaneous coccidioidomycosis, to highlight this mycosis that can start as cutaneous implantation, after trauma, and to emphasize the classification...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonifaz, Alexandro, Araiza, Javier, Arce, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511636/
http://dx.doi.org/10.1093/mmy/myac072.S6.4c
_version_ 1784797681257807872
author Bonifaz, Alexandro
Araiza, Javier
Arce, Martin
author_facet Bonifaz, Alexandro
Araiza, Javier
Arce, Martin
author_sort Bonifaz, Alexandro
collection PubMed
description S6.4 ONE HEALTH APPROACH FOR ENDEMIC MYCOES IN THE AMERICAS, SEPTEMBER 22, 2022, 4:45 PM - 6:15 PM:   OBJECTIVE: To present a series of cases of primary cutaneous coccidioidomycosis, to highlight this mycosis that can start as cutaneous implantation, after trauma, and to emphasize the classification criteria. METHODS: A series of cases of primary cutaneous coccidioidomycosis will be presented, all of them confirmed by mycological studies, fresh examinations, stains, and cultures, as well as their molecular identification; also confirmed by histopathology. RESULTS: A series of 22 cases of primary cutaneous coccidioidomycosis is presented, 16 (72.8%) in men, 6 (27.2%) in women. With an average age of 35.2 years, with the lowest case in a 14-year-old child and the highest at 72 years. All from rural and endemic areas. A total of 11 (50%) with fieldwork and the rest due to various injuries. The etiological agent was isolated in all of them: Coccidiodes posadasii in 16 (72.8%), C. immits in 3 and one by Coccidiodes sp. 20 cases were managed with itraconazole, with an average of 8 months and two more with a cycle of amphotericin B and subsequent itraconazole. Clinical and mycological cure was obtained in all. DISCUSSION: Primary cutaneous coccidioidomycosis, is considered an implantation mycosis, similar to other endemic ones, it occurs between 2%-10% of cases. It begins after trauma that inoculates the fungus, such as a primary chancre. To confirm that it is a primary form, Wilson's criteria must be met: the presence of skin trauma, regional lymphadenopathy, no evidence of pulmonary involvement, positive intradermal reaction, and low antibody titers. It may present auto involution and in immunosuppressed patients, it can spread. CONCLUSION: The initial cutaneous form of coccidioidomycosis is rare, usually seen in patients living in endemic areas, and usually present in patients with rural occupations. It has a variety of clinical forms, being confused with many diseases. Its diagnosis is simple, being the biopsy the most used, and it must be confirmed by mycological tests. It has a good prognosis and its main management is with itraconazole.
format Online
Article
Text
id pubmed-9511636
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95116362022-09-27 S6.4c Primary cutaneous implantation coccidioidomycosis Bonifaz, Alexandro Araiza, Javier Arce, Martin Med Mycol Oral Presentations S6.4 ONE HEALTH APPROACH FOR ENDEMIC MYCOES IN THE AMERICAS, SEPTEMBER 22, 2022, 4:45 PM - 6:15 PM:   OBJECTIVE: To present a series of cases of primary cutaneous coccidioidomycosis, to highlight this mycosis that can start as cutaneous implantation, after trauma, and to emphasize the classification criteria. METHODS: A series of cases of primary cutaneous coccidioidomycosis will be presented, all of them confirmed by mycological studies, fresh examinations, stains, and cultures, as well as their molecular identification; also confirmed by histopathology. RESULTS: A series of 22 cases of primary cutaneous coccidioidomycosis is presented, 16 (72.8%) in men, 6 (27.2%) in women. With an average age of 35.2 years, with the lowest case in a 14-year-old child and the highest at 72 years. All from rural and endemic areas. A total of 11 (50%) with fieldwork and the rest due to various injuries. The etiological agent was isolated in all of them: Coccidiodes posadasii in 16 (72.8%), C. immits in 3 and one by Coccidiodes sp. 20 cases were managed with itraconazole, with an average of 8 months and two more with a cycle of amphotericin B and subsequent itraconazole. Clinical and mycological cure was obtained in all. DISCUSSION: Primary cutaneous coccidioidomycosis, is considered an implantation mycosis, similar to other endemic ones, it occurs between 2%-10% of cases. It begins after trauma that inoculates the fungus, such as a primary chancre. To confirm that it is a primary form, Wilson's criteria must be met: the presence of skin trauma, regional lymphadenopathy, no evidence of pulmonary involvement, positive intradermal reaction, and low antibody titers. It may present auto involution and in immunosuppressed patients, it can spread. CONCLUSION: The initial cutaneous form of coccidioidomycosis is rare, usually seen in patients living in endemic areas, and usually present in patients with rural occupations. It has a variety of clinical forms, being confused with many diseases. Its diagnosis is simple, being the biopsy the most used, and it must be confirmed by mycological tests. It has a good prognosis and its main management is with itraconazole. Oxford University Press 2022-09-20 /pmc/articles/PMC9511636/ http://dx.doi.org/10.1093/mmy/myac072.S6.4c Text en © The Author(s) 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Oral Presentations
Bonifaz, Alexandro
Araiza, Javier
Arce, Martin
S6.4c Primary cutaneous implantation coccidioidomycosis
title S6.4c Primary cutaneous implantation coccidioidomycosis
title_full S6.4c Primary cutaneous implantation coccidioidomycosis
title_fullStr S6.4c Primary cutaneous implantation coccidioidomycosis
title_full_unstemmed S6.4c Primary cutaneous implantation coccidioidomycosis
title_short S6.4c Primary cutaneous implantation coccidioidomycosis
title_sort s6.4c primary cutaneous implantation coccidioidomycosis
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511636/
http://dx.doi.org/10.1093/mmy/myac072.S6.4c
work_keys_str_mv AT bonifazalexandro s64cprimarycutaneousimplantationcoccidioidomycosis
AT araizajavier s64cprimarycutaneousimplantationcoccidioidomycosis
AT arcemartin s64cprimarycutaneousimplantationcoccidioidomycosis